Researchers out of Australia are currently recruiting for one of the largest randomized controlled trials on vitamin D and health outcomes, called the D-Health study.
They are hoping to enroll 25,000 Australians ages 60-79 years to determine if vitamin D supplementation affects the risk of developing diseases such as cancer and heart disease.
The participants will be randomly selected to receive either 60,000 IU of vitamin D or placebo monthly for up to five years.
The researchers will gather information from hospital records, national health databases, and Medicare records.
“We hope that this study, linking with Medicare records and cancer registries, will be able to provide some definitive answers and advice,” said Dr. Rachel Neale, principal investigator.
Dr. Neale hopes that this study will add more evidence to vitamin D’s role in various areas of health. Other studies by Dr. Neale include one which found that participants living in areas with high UV radiation exposure had a 30-40% percent reduced risk ovarian, pancreatic, and esophageal cancer compared to those living in areas with low UV radiation exposure.
The D-Health study will provide more insight on the relationship between vitamin D and various health conditions and diseases, including different forms of cancer, due to its large sample size and long duration.
If you live in Australia and are interested in taking part in the study, visit http://dhealth.qimrberghofer.edu.au/ or call 1300 735 920 for more information.